Year |
Citation |
Score |
2016 |
Johnson AR, Qin Y, Cozzo AJ, Freemerman AJ, Huang MJ, Zhao L, Sampey BP, Milner JJ, Beck MA, Damania B, Rashid N, Galanko JA, Lee DP, Edin ML, Zeldin DC, et al. Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation. Molecular Metabolism. 5: 506-26. PMID 27408776 DOI: 10.1016/j.molmet.2016.04.005 |
0.8 |
|
2016 |
Johnson AR, Wilkerson MD, Sampey BP, Troester MA, Hayes DN, Makowski L. Cafeteria Diet-induced Obesity Causes Oxidative Damage in White Adipose. Biochemical and Biophysical Research Communications. PMID 27033600 DOI: 10.1016/j.bbrc.2016.03.113 |
0.8 |
|
2014 |
Kanaan YM, Sampey BP, Beyene D, Esnakula AK, Naab TJ, Ricks-Santi LJ, Dasi S, Day A, Blackman KW, Frederick W, Copeland RL, Gabrielson E, Dewitty RL. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease. Cancer Genomics & Proteomics. 11: 279-94. PMID 25422359 |
0.8 |
|
2014 |
Fu Z, Verderame TD, Leighton JM, Sampey BP, Appelbaum ER, Patel PS, Aon JC. Exometabolome analysis reveals hypoxia at the up-scaling of a Saccharomyces cerevisiae high-cell density fed-batch biopharmaceutical process. Microbial Cell Factories. 13: 32. PMID 24593159 DOI: 10.1186/1475-2859-13-32 |
0.8 |
|
2014 |
Beebe K, Sampey B, Watkins SM, Milburn M, Eckhart AD. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clinical and Translational Science. 7: 74-81. PMID 24422665 DOI: 10.1111/cts.12131 |
0.8 |
|
2012 |
Sampey BP, Freemerman AJ, Zhang J, Kuan PF, Galanko JA, O'Connell TM, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Newgard CB, Brauer HA, Troester MA, Makowski L. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. Plos One. 7: e38812. PMID 22701716 DOI: 10.1371/journal.pone.0038812 |
0.8 |
|
2011 |
Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring, Md.). 19: 1109-17. PMID 21331068 DOI: 10.1038/oby.2011.18 |
0.8 |
|
2011 |
Sampey BP, Lewis TD, Barbier CS, Makowski L, Kaufman DG. Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures. Experimental and Molecular Pathology. 90: 257-63. PMID 21281625 DOI: 10.1016/j.yexmp.2011.01.006 |
0.8 |
|
2007 |
Sampey BP, Carbone DL, Doorn JA, Drechsel DA, Petersen DR. 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction. Molecular Pharmacology. 71: 871-83. PMID 17164404 DOI: 10.1124/mol.106.029686 |
0.8 |
|
2007 |
Sampey BP, Stewart BJ, Petersen DR. Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal. The Journal of Biological Chemistry. 282: 1925-37. PMID 17107949 DOI: 10.1074/jbc.M610602200 |
0.8 |
|
2005 |
Ronis MJ, Butura A, Sampey BP, Shankar K, Prior RL, Korourian S, Albano E, Ingelman-Sundberg M, Petersen DR, Badger TM. Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition. Free Radical Biology & Medicine. 39: 619-30. PMID 16085180 DOI: 10.1016/j.freeradbiomed.2005.04.011 |
0.8 |
|
2004 |
Carbone DL, Doorn JA, Kiebler Z, Sampey BP, Petersen DR. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chemical Research in Toxicology. 17: 1459-67. PMID 15540944 DOI: 10.1021/tx049838g |
0.8 |
|
2003 |
Sampey BP, Korourian S, Ronis MJ, Badger TM, Petersen DR. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcoholism, Clinical and Experimental Research. 27: 1015-22. PMID 12824824 DOI: 10.1097/01.ALC.0000071928.16732.26 |
0.8 |
|
2002 |
Luckey SW, Taylor M, Sampey BP, Scheinman RI, Petersen DR. 4-hydroxynonenal decreases interleukin-6 expression and protein production in primary rat Kupffer cells by inhibiting nuclear factor-kappaB activation. The Journal of Pharmacology and Experimental Therapeutics. 302: 296-303. PMID 12065730 |
0.8 |
|
Low-probability matches |
2020 |
Cribbs AP, Terlecki-Zaniewicz S, Philpott M, Baardman J, Ahern D, Lindow M, Obad S, Oerum H, Sampey B, Mander PK, Penn H, Wordsworth P, Bowness P, de Winther M, Prinjha RK, et al. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism. Proceedings of the National Academy of Sciences of the United States of America. PMID 32123118 DOI: 10.1073/pnas.1919893117 |
0.01 |
|
2019 |
Sampey BP, Duke KS, Sampey GC, Gaukel EJ, Solyom A, Wring SA, He X, Zhu C, DeAngelis V, Schuchman EH, Coquery CM. The pro-inflammatory immunophenotype of a Farber disease mouse model is ameliorated by repeated dosing with RVT-801, a developmental enzyme replacement therapy for Farber disease Molecular Genetics and Metabolism. 126: S128. DOI: 10.1016/j.ymgme.2018.12.329 |
0.01 |
|
2019 |
Duke KS, Coquery CM, Gaukel EJ, He X, Schuchman EH, Rhodes M, Solyom A, Sampey BP. RVT-801, a developmental enzyme replacement therapy for Farber disease, ameliorates characteristic features of the disease phenotype in a Farber mouse model Molecular Genetics and Metabolism. 126: S50. DOI: 10.1016/j.ymgme.2018.12.112 |
0.01 |
|
2018 |
Gaukel E, Coquery C, Sampey B, Schuchman E, Wring SA. Prediction of the human equivalent dose (HED) of RVT-801, a recombinant human acid ceramidase, for the treatment of Farber disease Molecular Genetics and Metabolism. 123: S50. DOI: 10.1016/j.ymgme.2017.12.116 |
0.01 |
|
2018 |
Gaukel E, Coquery C, Sampey B, Schuchman E, Wring SA. Pharmacokinetics and tissue distribution of RVT-801, a recombinant human acid ceramidase, at efficacious doses in a murine model of Farber disease Molecular Genetics and Metabolism. 123: S50. DOI: 10.1016/J.YMGME.2017.12.115 |
0.01 |
|
2017 |
Roeloffs R, Sampey B, Lee J, Rhodes M, Soule E. 691 The effects of RVT-501 on DNCB-induced atopic dermatitis in NC/Nga mice Journal of Investigative Dermatology. 137: S119. DOI: 10.1016/j.jid.2017.02.714 |
0.01 |
|
2017 |
Asare E, Roeloffs R, Sampey BP, Ramaswamy S, Bruinsma B, Murck H, Friedhoff L. EVALUATION OF THE NEUROPROTECTIVE EFFECT OF INTEPIRDINE IN AN IN VITRO OXYGEN/GLUCOSE DEPRIVATION-INDUCED CYTOTOXICITY MODEL Alzheimer's & Dementia. 13: P1579-P1580. DOI: 10.1016/j.jalz.2017.07.751 |
0.01 |
|
2016 |
Sampey BP, Friedhoff L. P4-022: IN VIVO
Alterations in Brain Glucose Utilization with RVT-101, a 5Ht6 Inhibitor for the Treatment of Alzheimer’s Disease Alzheimer's & Dementia. 12: P1023-P1023. DOI: 10.1016/j.jalz.2016.06.2111 |
0.01 |
|
2015 |
Schuler KM, Rambally BS, DiFurio MJ, Sampey BP, Gehrig PA, Makowski L, Bae-Jump VL. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer. Cancer Medicine. 4: 161-73. PMID 25417601 DOI: 10.1002/cam4.353 |
0.01 |
|
2015 |
Roque DR, Schuler KM, Rambally BS, Sampey B, Everett R, Thakker D, Gehrig PA, O'Connor S, Makowski L, Bae-Jump VL. Molecular and metabolic differences of treatment responders versus non-responders in a phase 0 clinical trial of metformin in endometrial cancer. Journal of Clinical Oncology. 33: e22259-e22259. DOI: 10.1200/jco.2015.33.15_suppl.e22259 |
0.01 |
|
2014 |
Makowski L, Zhou C, Zhong Y, Kuan PF, Fan C, Sampey BP, Difurio M, Bae-Jump VL. Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer. Gynecologic Oncology. 133: 90-7. PMID 24680597 DOI: 10.1016/j.ygyno.2013.12.026 |
0.01 |
|
2014 |
Schuler K, Rambally B, Difurio M, Sampey B, Gehrig P, Makowski L, Bae-Jump V. Biological effects of metformin in a preoperative window clinical trial for endometrial cancer Gynecologic Oncology. 133: 5. DOI: 10.1016/J.YGYNO.2014.03.028 |
0.01 |
|
Hide low-probability matches. |